News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
32,249 Results
Type
Article (1346)
Company Profile (2)
Press Release (30901)
Section
Business (14614)
Career Advice (69)
Deals (2066)
Drug Development (3208)
Employer Resources (1)
FDA (505)
Job Trends (677)
News (19586)
Policy (969)
Tag
Academia (39)
Allergies (4)
Alliances (1021)
ALS (3)
Alzheimer's disease (36)
Antibody-drug conjugate (ADC) (10)
Approvals (519)
Artificial intelligence (4)
Autoimmune disease (1)
Automation (3)
Bankruptcy (3)
Best Places to Work (591)
Biotechnology (1)
Bladder cancer (5)
Brain cancer (1)
Breast cancer (26)
Cancer (175)
Cardiovascular disease (16)
Career advice (66)
Career pathing (1)
CAR-T (8)
Cell therapy (15)
Cervical cancer (2)
Clinical research (2899)
Collaboration (23)
Company closure (1)
Compensation (44)
COVID-19 (79)
CRISPR (5)
C-suite (3)
Cystic fibrosis (2)
Data (249)
Depression (3)
Diabetes (18)
Diagnostics (398)
Digital health (2)
Drug discovery (2)
Drug pricing (3)
Duchenne muscular dystrophy (2)
Earnings (13713)
Employer resources (1)
Events (4225)
Executive appointments (8)
FDA (703)
Frontotemporal dementia (1)
Funding (21)
Gene editing (6)
Gene therapy (9)
GLP-1 (24)
Government (95)
Guidances (146)
Healthcare (865)
HIV (1)
IgA nephropathy (3)
Immunology and inflammation (7)
Infectious disease (83)
Inflation Reduction Act (1)
Influenza (1)
Intellectual property (3)
Interviews (9)
IPO (1623)
Job creations (113)
Job search strategy (55)
Labor market (3)
Layoffs (12)
Legal (162)
Liver cancer (4)
Lung cancer (34)
Lymphoma (14)
Management (1)
Manufacturing (8)
MASH (8)
Medical device (696)
Medtech (699)
Mergers & acquisitions (466)
Metabolic disorders (37)
Multiple sclerosis (1)
NASH (2)
Neurodegenerative disease (3)
Neuropsychiatric disorders (3)
Neuroscience (69)
NextGen: Class of 2025 (163)
Non-profit (48)
Obesity (9)
Opinion (2)
Ovarian cancer (23)
Pain (1)
Pancreatic cancer (8)
Parkinson's disease (2)
Patents (8)
Patient recruitment (10)
Peanut (2)
People (791)
Pharmacy benefit managers (1)
Phase I (630)
Phase II (1194)
Phase III (1181)
Pipeline (447)
Postmarket research (169)
Preclinical (286)
Prostate cancer (6)
Radiopharmaceuticals (13)
Rare diseases (13)
Real estate (166)
Recruiting (1)
Regulatory (802)
Reports (8)
Research institute (49)
Resumes & cover letters (4)
Schizophrenia (10)
Series A (3)
Series B (3)
Sickle cell disease (5)
Special edition (4)
Spinal muscular atrophy (8)
Startups (56)
Tariffs (2)
Vaccines (12)
Venture capital (2)
Weight loss (11)
Women's health (4)
Date
Today (6)
Last 7 days (40)
Last 30 days (94)
Last 365 days (2107)
2025 (1707)
2024 (2168)
2023 (2467)
2022 (2984)
2021 (2960)
2020 (2646)
2019 (1568)
2018 (1202)
2017 (950)
2016 (633)
2015 (1067)
2014 (779)
2013 (449)
2012 (569)
2011 (614)
2010 (607)
Location
Africa (23)
Alabama (5)
Alaska (1)
Arizona (18)
Asia (2195)
Australia (173)
California (520)
Canada (130)
China (43)
Colorado (36)
Connecticut (26)
Delaware (14)
Europe (4159)
Florida (89)
Georgia (24)
Idaho (3)
Illinois (30)
India (1)
Indiana (31)
Japan (19)
Kansas (2)
Kentucky (1)
Louisiana (4)
Maine (4)
Maryland (67)
Massachusetts (346)
Michigan (22)
Minnesota (26)
Missouri (7)
Montana (4)
Nevada (4)
New Hampshire (8)
New Jersey (185)
New York (136)
North Carolina (79)
Northern California (250)
Ohio (10)
Oregon (1)
Pennsylvania (116)
South America (34)
Southern California (217)
Tennessee (4)
Texas (85)
United States (1948)
Utah (23)
Virginia (4)
Washington D.C. (2)
Washington State (42)
Wisconsin (2)
32,249 Results for "112".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Gynecology Drugs Market Size to Reach USD 112.6 Billion by 2034 Rising Gynecological Disorders and Health Awareness Drive Market Growth
The global gynecology drugs market size is forecasted to reach around USD 112.6 billion by 2034, increasing from USD 69.79 billion in 2024 and representing a remarkable CAGR of 4.9% from 2025 to 2034.
October 16, 2025
·
1 min read
Press Releases
Nuclear Medicine Market worth $38.52 billion by 2032 with 11.2% CAGR - Exclusive Report by Coherent Market Insights
June 12, 2025
·
1 min read
Press Releases
Rockwell Medical to Exhibit at DialysisTechConneXion42 in Booth# 112
March 11, 2025
·
4 min read
Press Releases
Araceli Biosciences Closes $11.2M Seed Financing to Change the Pace of Drug Discovery
April 24, 2025
·
2 min read
Press Releases
Akeso Announces First Patient Enrolled in the Phase III Trial（AK112-312/HARMONi-GI6）of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer
July 16, 2025
·
5 min read
Press Releases
Downstream Processing Market Size to Surge USD 112.86 Billion by 2034
February 26, 2025
·
1 min read
Press Releases
Ferring Unveils New Data with ADSTILADRIN® (nadofaragene firadenovec-vncg) at 112th Annual Meeting of the Japanese Urological Association
April 21, 2025
·
11 min read
Press Releases
AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing
February 3, 2025
·
5 min read
Press Releases
Promontory Therapeutics Announces Successful End of Phase 2 Meeting with US FDA on Phase 3 Registrational Study Design for PT-112 in Patients with Metastatic Castration-Resistant Prostate Cancer
May 20, 2025
·
3 min read
Zura Bio Announces Oversubscribed $112.5 Million Private Placement
Zura Bio Limited today announced that it has entered into subscription agreements for a private placement that is expected to result in gross proceeds of approximately $112.5 million, before deducting placement agent fees and offering expenses (the “Private Placement”).
April 18, 2024
·
7 min read
1 of 3,225
Next
